Stockley’s Drug Interactions November 2023 Update

For this update of Stockley’s Drug Interactions there are 94 new monographs and there have been updates to 58 existing monographs.

The following drugs have been added: avapritinib, baloxavir marboxil, bictegravir, dacomitinib,  erdafitinib, gilteritinib,  favipiravir, fedratinib, larotrectinib, lasmiditan, lorlatinib, maribavir, pexidartinib, selumetinib, sotorasib, upadacitinib, vericiguat, and zanubrutinib. In addition, dicloxacillin and flucloxacillin have been reviewed and updated with respect to induction of CYP3A4.